These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31040059)

  • 21. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.
    Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A
    Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35.
    Scopinaro N; Adami GF; Papadia FS; Camerini G; Carlini F; Briatore L; Andraghetti G; Catalano M; Cordera R
    Obes Surg; 2014 Jul; 24(7):1036-43. PubMed ID: 24647849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does vitamin D status correlate with insulin resistance in obese prediabetic patients? An Egyptian multicenter study.
    Hetta HF; Fahmy EM; Mohamed GA; Gaber MA; Elkady A; Elbadr MM; Al-Kadmy IMS
    Diabetes Metab Syndr; 2019; 13(5):2813-2817. PubMed ID: 31425941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemoglobin A1c and C-reactive protein are independently associated with blunted nocturnal blood pressure dipping in obesity-related prediabetes.
    Lane-Cordova AD; Kalil GZ; Wagner CJ; Sindler AL; Fiedorowicz JG; Ajibewa T; Haynes WG; Pierce GL
    Hypertens Res; 2018 Jan; 41(1):33-38. PubMed ID: 29070829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric Embolization as Treatment for Overweight Patients; Efficacy and Safety.
    Elens S; Roger T; Elens M; Rommens J; Sarafidis A; Capelluto E; Delcour C
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):513-519. PubMed ID: 30488305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.
    Sarfati D; McLeod M; Stanley J; Signal V; Stairmand J; Krebs J; Dowell A; Leung W; Davies C; Grainger R
    Trials; 2018 Mar; 19(1):161. PubMed ID: 29506562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.
    van de Laar AW; de Brauw LM; Meesters EW
    Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of glycated haemoglobin (HbA1
    Mustafa IO; Tanko Y; Yusuf R; Musa SA
    Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels.
    Ebenibo S; Edeoga C; Wan J; Dagogo-Jack S
    Metabolism; 2014 Jun; 63(6):767-72. PubMed ID: 24641885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth.
    Chan CL; Pyle L; Newnes L; Nadeau KJ; Zeitler PS; Kelsey MM
    J Clin Endocrinol Metab; 2015 Mar; 100(3):902-10. PubMed ID: 25532041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediabetes defined by HbA
    Rodriguez-Segade S; Rodriguez J; Camiña F; Sanmartín-Portas L; Gerpe-Jamardo J; Pazos-Couselo M; García-López JM; Alonso-Sampedro M; González-Quintela A; Gude F
    Acta Diabetol; 2019 Sep; 56(9):1023-1030. PubMed ID: 31115752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of impaired glucose metabolism on weight loss in multidisciplinary childhood obesity treatment.
    Kloppenborg JT; Gamborg M; Fonvig CE; Nielsen TRH; Pedersen O; Johannesen J; Hansen T; Holm JC
    Pediatr Diabetes; 2018 May; 19(3):366-374. PubMed ID: 29159854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of lifestyle interventions in the reversion to normoglycemia in Korean prediabetics: One-year results from a randomised controlled trial.
    Nah EH; Chu J; Kim S; Cho S; Kwon E
    Prim Care Diabetes; 2019 Jun; 13(3):212-220. PubMed ID: 30583933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour.
    de Boer SA; Lefrandt JD; Petersen JF; Boersma HH; Mulder DJ; Hoogenberg K
    Int J Clin Pharm; 2016 Feb; 38(1):144-51. PubMed ID: 26597956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One Anastomosis Gastric Bypass/Minigastric Bypass in Patients with BMI < 35 kg/m
    Navarrete Aulestia S; Leyba JL; Navarrete Llopis S; Pulgar V
    Obes Surg; 2019 Dec; 29(12):3987-3991. PubMed ID: 31297740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California.
    Tester J; Sharma S; Jasik CB; Mietus-Snyder M; Tinajero-Deck L
    Diabetes Metab Syndr; 2013; 7(3):161-5. PubMed ID: 23953182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T-emerge 7 study).
    Hollander P; Lasko B; Barnett AH; Bengus M; Kanitra L; Pi-Sunyer FX; Balena R
    Obesity (Silver Spring); 2013 Feb; 21(2):238-47. PubMed ID: 23404788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between prediabetes diagnosis and body mass index trajectory of overweight and obese adolescents.
    Vajravelu ME; Lee JM; Shah R; Shults J; Amaral S; Kelly A
    Pediatr Diabetes; 2020 Aug; 21(5):743-746. PubMed ID: 32314478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes.
    Paul SK; Shaw JE; Montvida O; Klein K
    Diabetes Obes Metab; 2016 Dec; 18(12):1244-1252. PubMed ID: 27502528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.